YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...
Meeting Era Biology at AACC 2023
The AACC congress, the American Association for Clinical Chemistry, is the premier global gathering for laboratory medicine professionals. This year, it will take p...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...
On June 28, the “National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crab Marine Biomedicine Industrial Park” invested and c...
On May 19th, Era Biology host the global live webinar. The webinar talks about three different solutions using fungus (1-3)-β-D Glucan Test to achieve early and rapid diagnosis of invasive fungal d...